Catheter-Related Bloodstream Infections Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,300.00$ 8,900.00

Catheter-Related Bloodstream Infections (CRBSIs) Market by Type (Non-antibiotic, Antibiotic, Others), by route of administration (Oral and Intravenous), by Source of Infection/Causative Agents (Staphylococcus aureus, P. aeruginsa, Acinetobacter baumannii, E. Coli, K. Pneuminiae, Candida Sp., Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

 

$ PRICE - $ 3,300.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,300.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Catheter-Related Bloodstream Infections (CRBSIs) Market is valued at USD 1.4 billion in 2021 and is poised to grow at a significant CAGR over 2022–2028. The global market is predicted to be driven by an increase in the prevalence of bloodstream infections. According to a study in the journal Continuing Education in Anaesthesia, Critical Care & Pain, catheter-related bloodstream infections happen in about 3% of catheterizations, although they can happen up to 16% of the time. Inaccurate diagnoses have serious consequences, including procedure difficulties that raise morbidity and mortality. Therefore, it is crucial to identify catheter-related bloodstream infections accurately. Moreover, the risk of CRBSI is elevated by hospital-acquired infections. According to the International Journal of Critical Illness and Injury Science, 10 to 20 percent of hospital-acquired infections in the United Kingdom are caused by CRBSI. The infrastructure for health care is being modernized by governments in developing nations, which is anticipated to expand access to healthcare. Additionally, healthcare-associated infections are a significant problem in underdeveloped countries. Therefore, the global market is presented with a huge potential due to the rise in demand for the items brought on by the patient population growth.

Catheter-Related Bloodstream Infections Market

MARKET SUMMARY
-
x%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Catheter-Related Bloodstream Infections Market

  • The catheter-related bloodstream infections market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The catheter-related bloodstream infections market is segmented based on type, route of administration, source of infection/causative agents, distribution channel, and geography.
Key Players
  • CorMedix, Inc.
  • Geistlich Pharma
  • TauroPharm GmbH
  • Fresenius Medical Care
  • Citius Pharmaceuticals
Catheter-Related Bloodstream Infections Market Dynamics

The patient is more likely to develop CRBSI if they have immunosuppression, whether it is absolute (like that seen in the critically ill) or relative (like that found in diseases of the blood). The rate of CRBSI is also influenced by the microbiological environment, with higher rates in the intensive care unit than in the outpatient setting. The injection of TPN, frequent catheter access, and improper aseptic procedures are risk factors for CRBSI. The increasing risk of CRBSI is driving the market worldwide. On the other hand, regulations related to culture media and micro-organisms in laboratories restrain the market.


North-America Got Significant Share

Catheter-Related Bloodstream Infections Market

The Catheter-Related Bloodstream Infections (CRBSIs) market in North America are likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly. Due to its well-established health care infrastructure, North America is anticipated to have a significant share of the global market for catheter-related bloodstream infections over the forecast period. From 2020 to 2030, Europe is predicted to be the second-largest market. Due to the rise in hospital-acquired conditions, the catheter-related bloodstream infections market in the Asia Pacific is anticipated to expand quickly over the projected period. According to the Department of Communicable Disease of the World Health Organization, developing countries have a 2 to 20-fold higher risk of healthcare-associated infections than industrialized nations.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The catheter-related bloodstream infections market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Catheter-Related Bloodstream Infections (CRBSIs) Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The catheter-related bloodstream infections market is projected to expand at a CAGR of x% during the forecast period

CorMedix, Inc., Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, Citius Pharmaceuticals

North America is the fastest-growing region for catheter-related bloodstream infections market


Report

Company Profile

  • Merck Sharp & Dohme Corp
  • CorMedix, Inc.
  • Geistlich Pharma
  • TauroPharm GmbH
  • Fresenius Medical Care
  • Citius Pharmaceuticals

Description

Catheter-Related Bloodstream Infections (CRBSIs) Market is valued at USD 1.4 billion in 2021 and is poised to grow at a significant CAGR over 2022–2028. The global market is predicted to be driven by an increase in the prevalence of bloodstream infections. According to a study in the journal Continuing Education in Anaesthesia, Critical Care & Pain, catheter-related bloodstream infections happen in about 3% of catheterizations, although they can happen up to 16% of the time. Inaccurate diagnoses have serious consequences, including procedure difficulties that raise morbidity and mortality. Therefore, it is crucial to identify catheter-related bloodstream infections accurately. Moreover, the risk of CRBSI is elevated by hospital-acquired infections. According to the International Journal of Critical Illness and Injury Science, 10 to 20 percent of hospital-acquired infections in the United Kingdom are caused by CRBSI. The infrastructure for health care is being modernized by governments in developing nations, which is anticipated to expand access to healthcare. Additionally, healthcare-associated infections are a significant problem in underdeveloped countries. Therefore, the global market is presented with a huge potential due to the rise in demand for the items brought on by the patient population growth.

Reviews

There are no reviews yet.

Be the first to review “Catheter-Related Bloodstream Infections Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX